UNSPSC 41142023: Malic dehydrogenase test system

In this classification, Malic dehydrogenase test system connotes a device used to measure Malic dehydrogenase levels. US FDA regulates Malic dehydrogenase test system under 21 CFR 862.1500 and under FDA product code JMS.

UNSPSC 41142023 Malic dehydrogenase test system is a Commodity code under which state and local governments procure diagnostic reagent kits and reference materials for forensic and clinical laboratory analysis, including Direct ELISA testing kits for substance screening, mosquito-borne disease detection systems, certified drug standards for method validation, and DNA screening kits. Recent solicitations show state and local buyers acquiring immunoanalysis reagents for controlled substance testing, West Nile Virus and dengue test kits for vector surveillance, ISO/IEC 17025:2017-accredited drug reference standards with certificates of analysis, and QIAxcel DNA screening and marker kits for laboratory instrumentation. The issuing bodies include state crime laboratories, state health and human services agencies, county forensic laboratories, state environmental and financial regulation departments, and state departments of criminal justice—primarily high-assurance forensic, public health, and laboratory quality-control functions where reagent and standard specification compliance and vendor performance history carry significant weight in evaluation.

Recent activity concentrates in Texas and Florida, with secondary presence in Illinois. The Texas Department of Public Safety issued IFB 405-26R0008445A on July 9, 2026 (due July 23, 2026) for Direct ELISA testing kits spanning cannabinoids, opiates, amphetamines, benzodiazepines, and other controlled substances in 12 line items, evaluated on best value under Texas Government Code 2156.007 with vendor performance rating disqualification thresholds. Pinellas County, Florida, in partnership with the Florida Department of Law Enforcement, solicited Invitation to Quote 26-0305-ITQ (posted April 23, 2026, due April 23, 2026) for 131 line items of certified reference drug standards meeting ISO 17034:2016 accreditation, with $49,034.00 of $72,126.85 in federal Coverdell Act funds designated for standards procurement and SBE preference available to Florida Certified Small Business Enterprises. The Texas Health and Human Services Commission procured QIAxcel and QIAamp DNA screening kits through IFB HHS0016902v2 with a January 29, 2026 deadline and historical annual spend of $25,050.00–$30,000.00 for similar goods in Fiscal Year 2025. The Illinois Department of Financial and Professional Regulation established a joint purchase master contract for RAMP West Nile Virus and dengue test kits through sole source award to ADAPCO, LLC (notice of intent posted May 4, 2026, hearing May 20, 2026), serving multiple state and local health jurisdictions nationwide.